Related Experiment Video
Updated: Aug 9, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Medical treatment of hypertrophic cardiomyopathy
M V Sherrid1, D Gunsburg, A Sharma
1Hypertrophic Cardiomyopathy Program, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, Division of Cardiology, 3B-30, 1000 10th Avenue, New York, NY 10019, USA. msherrid@slrhc.org
Insights
Current hypertrophic cardiomyopathy (HCM) treatments focus on symptom relief. This review explores evolving pathophysiology, available medical agents, and strategies for managing outflow obstruction and arrhythmias.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition often managed symptomatically.
- Evolving understanding of HCM pathophysiology is crucial for optimizing treatment strategies.
Purpose of the Study:
- To review current medical therapies for hypertrophic cardiomyopathy (HCM).
- To discuss novel therapeutic concepts and agents for HCM management.
- To outline strategies for reducing outflow gradients and managing arrhythmias in HCM patients.
Main Methods:
- Review of current medical therapy for HCM.
- Discussion of new pathophysiological concepts.
- Analysis of available and investigational agents.
- Consideration of antiarrhythmic therapy.
Main Results:
- Medical therapy aims to alleviate symptoms like exercise intolerance, angina, and syncope.
- Understanding pathophysiology guides current and future treatment approaches.
- Negative inotropes are key for managing obstructive HCM.
- Newer agents and antiarrhythmic strategies are under investigation.
Conclusions:
- Medical therapy for HCM is advancing with new pathophysiological insights.
- Effective management involves symptom control, outflow gradient reduction, and arrhythmia treatment.
- Ongoing research promises improved therapeutic options for HCM patients.
Abstract:
Current medical therapy of hypertrophic cardiomyopathy (HCM) is tailored to relieve symptoms of exercise intolerance, angina, or syncope. In recent years, new concepts in the pathophysiology of HCM have evolved. These concepts underlie our medical therapy and are discussed first in this review. Subsequently, the agents available for the medical treatment of HCM are discussed, along with a practical strategy for rapid medical reduction of outflow gradients. The mechanism of benefit of negative inotropes for obstruction is described, and newer agents under investigation are discussed. Finally, antiarrhythmic therapy for troubling atrial and ventricular arrhythmias is considered.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

